Analysis of variation in L-365,260 competition curves in radioligand binding assays

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1717-1726

  Harper, E A ^a   Roberts, S P ^a   Shankley, N P ^a   Black, J W ^a  

^a James Black Foundation   (United Kingdom)

Author keywords

Cholecystokinin; Gastrin; Guinea pig gastric glands; L 365,260; Mouse cortex; Rat cortex; 125I BH CCK8S

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; GASTRIN ANTAGONIST; GASTRIN RECEPTOR; IODINE 125; RADIOLIGAND; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING SITE; BRAIN CORTEX; CONTROLLED STUDY; GUINEA PIG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; STOMACH GLAND;

EID: 0029899545     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15597.x     Document Type: Article

References (52)

1. BEINBORN, M., LEE, Y.-M., MCBRIDE, E.W., QUINN, S.M. & KOPIN, A.S. (1993). A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature, 362, 348-350.
2. B/gastrin receptor antagonists. Eur. J. Pharmacol., 262, 233-245.
3. BOUSSO-MITTLER, D., GALRON, R & SOKOLOVSKY, M. (1991). Endothelin/sarafatoxin receptor heterogeneity: Evidence for different glycosylation in receptors from different tissue. Biochem. Biophys. Res. Commun., 178, 921-926.
4. 3H]-pentagastrin binding in guinea-pig gastric glands an alternative convenient ligand for receptor binding assay. Biochem. Biophys. Res. Commun., 134, 895-899.
5. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099.
6. CLARKE, C.R., DAUM, P. & HUGHES, J. (1986). A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK8 and CCK4 cholecystokinin receptor binding site. J. Neurochem., 46, 1094-1101.
7. CORP, E.S., MCQUADE, J., MORAN, T.H. & SMITH, G.P. (1993). Characterisation of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res., 623, 161-166.
8. B receptor. Eur. J. Pharmacol., 268, 29-41.
9. DIXON, W.J. (1992). BMDP Statistical Software. University of California Press.
10. 3H]-SNF 8702. Mol. Pharmacol., 42, 1089-1095.
11. B receptors in guinea-pig synaptoneurosomes. Eur. J. Pharmacol., 226, 35-41.
12. 125I]-BH-[leu15]-gastrin-(5-17), on binding to canine fundic mucosal cells and Jurkat cells. Int. J. Peptide Protein Res., 44, 348-358.
13. GOLDSTEIN, A. & BARRETT, R.W. (1987). Ligand dissociation constants form competition binding assays: errors associated with ligand depletion. Mol. Pharmacol., 31, 603-606.
14. 125I]-BH-CCK8S in guinea-pig gastric glands and mouse and rat cortex assays; evidence for variable expression of two CCK/gastrin receptors. Br. J. Pharmacol., 114, 221P.
15. HUGHES, J., BODEN, P.R., COSTALL, B., DOMENEY, A., KELLY, E., HORWELL, D.C., HUNTER, J.C., PINNOCK, R.D. & WOODRUFF, G.N. (1990). Development of a class of selective cholecystokinin type B receptor antagonists having a potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A., 87, 6728-6732.
16. A receptor antagonist. Br. J. Pharmacol., 108, 734-740.
17. B/gastrin receptor in guinea-pig cerebral cortex and gastric mucosa. Mol. Pharmacol., 43, 595-602.
18. INOMOTO, Y., KINOSHITA, Y., NAKAMURA, A., ARIMA, N., YAMASHITA, Y., NAKATA, H., YAMAMURA, Y., HOSODA, S. & CHIBA, T. (1993). Characterisation of gastrin/CCK receptors on gastric carcinoid tumor membrane of Mastomys natalensis. Reg. Peptides, 43, 149-158.
19. JAGERSCHMIDT, A., POPOVICI, T., O'DONOHUE, M. & ROQUES, B.P. (1994). Identification and characterisation of various cholecystokin B receptor mRNA forms in rat brain tissue and partial determination of the cholecystokinin B receptor gene structure. J. Neurochem., 63, 1199-1206.
20. KALINDJIAN, S.B., BODKIN, M.J., BUCK, I.M., DUNSTONE, D.J., LOW, CM.R., MCDONALD, I.M., PETHER, M.J. & STEEL, K.I. (1994). A new class of non-peptide cholecystokinin-B/gastrin receptor antagonists based on dibenzobicyclo[2.2.2]octane. J. Med. Chem., 37, 3671-3674.
21. KLEVELAND, P.M. & WALDUM, H.L. (1991). The gastrin receptor assay. Scand. J. Gastroenterol., 26 (suppl. 180), 62-69.
22. B receptor heterogeneity. J. Pharmacol. Exp. Ther., 255, 1278-1286.
23. KOPIN, A.S., LEE, Y.-M., MCBRIDE, E.W., MILLER, L.J., LU, M., LIN, H.Y., KOLAKOWSKI, L.F. & BEINBORN, M. (1992). Expression cloning and characterisation of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. U.S.A., 89, 3605-3609.
24. 2+ mobilisation in a pituitary cell line. Eur. J. Pharmacol., 221, 99-105.
25. KWATRA, M.M. & HOSEY, M.M. (1986). Phosphorylation of the cardiac muscarinic receptor in intact chick heart and its regulation by a muscarinic agonist. J. Biol. Chem., 261, 12429-12432.
26. LEE, Y.-M., BEINBORN, M., MCBRIDE, E.W., LU, M., KOLAKOWSKI, L.F. & KOPIN, A.S. (1993). The human brain cholecystokinin-B/gastrin receptor. J. Biol. Chem., 268, 8164-8168.
27. LIGNON, M.-F., BERNAD, N. & MARTINEZ, J. (1991). Pharmacological characterisation of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line. Mol. Pharmacol., 39, 615-620.
28. 2+ concentration in the human JURKAT T lymphocyte cell line. Eur. J. Pharmacol. (Mol. Pharmacol.), 245, 242-246.
29. LOTTI, V.L. & CHANG, R.S.L. (1989). A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur. J. Pharmacol., 162, 273-280.
30. MAGOUS, R., GALLEYRAND, J.-C. & BALI, J.-P. (1988). Common or distinct receptors for gastrin and cholecystokinin in gastric mucosa. Biochim. Biophys. Acta, 1010, 357-362.
31. 2 pharmacological selectivity. Mol. Pharmacol., 44, 346-355.
32. MOTULSKY, H.J., MAHAN, L.C. & INSEL, P.A. (1985). Radioligand, agonists and membrane receptors on intact cells: data analysis in a bind. Trends Pharmacol. Sci., 6, 317-319.
33. NISHIDA, A., MIYATA, K., TSUTSUMI, R., YUKI, H., AKUZAWA, S., KOBAYASHI, A., KAMATO, T., ITO, H., YAMANO, M., KATUYMA, Y., SATOH, M., OHTA, M & HONDA, K. (1994). Pharmacological profile of (R)-1-[2,3-Dihydro-1-(2′-methyl-phenacyl)-2-oxo-5′phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther., 269, 725-731.
34. OHTSUKA, T., KUDOH, T., SHIMMA, N., KOTAKI, H., NAKAYAMA, N., ITEZONO, Y., FUJISAKI. N., WATANABE, J., YOKOSE, K. & SETA, H. (1992). Tetronothiodin, a novel cholecystokinin type B receptor antagonist produced by Streptomyces sp. J. Antibiotics. 45, 140-143.
35. PALMER-SMITH, J., RICKBAUGH, C.A., MCLAUGHLIN, P.J. & ZAGON, I.S. (1993). Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Am. J. Physiol., 265, G149-G155.
36. PATEL, M. & SPRAGGS, C.F. (1992). Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum. Eur. J. Pharmacol., 106, 275-282.
37. PENDLEY, C.E., FITZPATRICK, L.R., EWING, R.W., MOLINO, B.F. & MARTIN, G.E. (1993). The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat. J. Pharmacol. Exp. Ther., 265, 1348-1354.
38. PISEGNA, J.R., DE WEERTH, A., HUPPI, K. & WANK, S.A. (1992). Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosomal localisation. Biochem. Biophys. Res. Commun., 189, 295-303.
39. 125I]-CCK8 to guinea-pig gastric glands differ: is there more than one binding site for peptides of the CCK-gastrin family? Biochem. Biophys. Res. Commun., 123, 641-647.
40. B/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays. Br. J. Pharmacol., (details at press).
41. RUBIN, N.H., SINGH, P., ALINDER, G., GREELEY, G.H., RAYFORD, P.L., RIETVELD, W.J. & THOMPSON, J.C. (1988). Circadian rhythms in gastrin receptors in rat fundic stomach. Digestive Diseases Sci., 33, 931-937.
42. SCHUTZ, W., NANOFF, C. & FREISSMUTH, M. (1988). The fallacy of non-selectivity of radioactive ligands. Trends Pharmacol. Sci., 9, 261-264.
43. 2+ mobilisation. Eur. J. Pharmacol., 267, 215-223.
44. SNEDECOR, G. W. & COCHRAN, W.G. (1967). In: Statistical Methods. Iowa, U.S.A: Iowa State University Press.
45. SONG, I., BROWN, D.R., WITSHIRE, R.N., GANTZ, I., TRENT, J.M. & YAMADA, T. (1993). The human gastrin/cholecystokinin type B receptor gene: Alternative splice donor site in exon 4 generate two variant mRNAs. Proc. Natl. Acad. Sci. U.S.A., 90, 9085-9089.
46. SOUMARON, A., CHERET, A.M. & LEWIN, M.J.M. (1977). Localisation of gastrin receptors in intact isolated and separated rat fundic cells. Gastroenterology., 73, 900-903.
47. B/gastrin receptor mediated changes in intracellular calcium in AR42J cells. Br. J. Pharmacol., 107, 73P.
48. WANK, S.A., PISEGNA J,R, & DE WEERTH, A. (1992). Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc. Natl. Acad. Sci. U.S.A., 89, 8691 8695.
49. WANK, S.A., PISEGNA, J.R. & POIROT, S.S. (1994). Functional significance of potential splice variants of the human cholecystokinin (CCK) B receptor. Gastroenterology., 106, A850.
50. WATSON, S.P. & GIRDLESTONE, D. (1995). Receptor Nomenclature Supplement. Trends Pharmacol. Sci.,
51. WELLS, J.W., BIRDSALL, N.J.M., BURGEN, A.S.V. & HULME, E.C. (1980). Competitive binding studies with multiple sites; effects arising from depletion of the free radioligand. Biochim. Biophvs. Acta, 632, 464-469.
52. WILLIAMS, J.A., BAILEY, A.C. & ROACH, E. (1988). Temperature dependence of high-affinity CCK receptor binding and CCK internalisation in rat pancreatic acini. Am. J. Phrsiol., 254, G513-G521.